The Role of Nuclear Cardiac Imaging in Infective Endocarditis

Current Cardiovascular Imaging Reports

Volumn 10, Issue 7, 2017, Pages

  Sollini, Martina ^a   Boni, Roberto ^b   Antunovic, Lidija ^c   Kirienko, Margarita ^a   Lazzeri, Elena ^d   Erba, Paola Anna ^d,e  

^a HUMANITAS UNIVERSITY   (Italy)

^b PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d UNIVERSITY HOSPITAL OF PISA   (Italy)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

Cardiac imaging; Endocarditis team; Infective endocarditis; Radiolabeled leukocyte scintigraphy; 18F FDG PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BACTERIAL ENDOCARDITIS; CARDIAC IMAGING; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; INFLAMMATION; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

EID: 85019916469     PISSN: 19419066     EISSN: 19419074     Source Type: Journal    
DOI: 10.1007/s12410-017-9421-5     Document Type: Review

References (49)

1. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169:463–73.
2. Vogkou C, Vlachogiannis N, Palaiodimos L, Kousoulis A. The causative agents in infective endocarditis: a systematic review comprising 33,214 cases. Eur J Clin Microbiol Infect Dis. 2016;35:1227–45.
3. Thuny F, Hubert S, Tribouilloy C, Le Dolley Y, Casalta JP, Riberi A, et al. Sudden death in patients with infective endocarditis: findings from a large cohort study. Int J Cardiol. 2013;162:129–32.
4. Htwe TH, Khardori NM. Cardiac emergencies: infective endocarditis, pericarditis, and myocarditis. Med Clin North Am. 2012;96:1149–69.
5. Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi M-F, Barsic B, Bouza E, et al. Current features of infective endocarditis in elderly patients: results of the international collaboration on endocarditis prospective cohort study. Arch Intern Med. 2008;168:2095–103.
6. Osler W. The Gulstonian lectures, on malignant endocarditis. Br Med J. 1885;1:1885.
7. Durack DT, Lukes ASBD. New criteria for diagnosis of infective endocarditis: utilization of specific endocardiographic findings. Am J Med. 1994;96:200–9.
8. Habib G, Derumeaux G, Avierinos JF, Casalta JP, Jamal F, Volot F, et al. Value and limitations of the duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999;33:2023–9.
9. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.
10. 99m Tc-HMPAO-labeled leukocyte SPECT/CT in a large series of patients with infectiosu endcarditis.
11. •• Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 36:ehv319. These are the first clinical guidelines which included nuclear medicine imaging in the diagnostic alghorithm of infective endocarditis and defined the “Endocarditis Team”.
12. Iung B, Erba PA, Petrosillo N, Lazzeri E. Common diagnostic flowcharts in infective endocarditis. Q J Nucl Med Mol imaging Off Publ Ital Assoc Nucl Med [and] Int Assoc Radiopharmacol (IAR), [and] Sect Soc Radiopharm. 2014;58:55–65.
13. Erba PA, Sollini M, Boni R, Lazzeri E. Other imaging modalities in infective endocarditis diagnosis. In: Habib G, editor. Infect. Endocarditis Epidemiol. Diagnosis., imaging, Ther. Prev. 1st ed. Heidelberg: Springer-Verlag Berlin; 2016. p. 51–80.
14. Caobelli F, Wollenweber T, Bavendiek U, Kühn C, Schütze C, Geworski L, et al. Simultaneous dual-isotope solid-state detector SPECT for improved tracking of white blood cells in suspected endocarditis. Eur. Heart J. 2016;ehw231.
15. 99mTc-HMPAO-labelled leucocytes in musculoskeletal infections. Eur J Nucl Med Mol Imaging. 2013;40:1760–9.
16. Lazzeri E, Israel O, Erba P, Chakravartty R, Comin J, Jamar F, et al. Comment on Aksoy et al.: FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection. Eur J Nucl Med Mol Imaging. 2014;41:1811–2.
17. Hyafil F, Rouzet F, Lepage L, Benali K, Raffoul R, Duval X, et al. Role of radiolabelled leucocyte scintigraphy in patients with a suspicion of prosthetic valve endocarditis and inconclusive echocardiography. Eur. Heart J. Cardiovasc. Imaging. 2013;14:586–94.
18. Hyafil F, Rouzet F, Le Guludec D. Nuclear imaging for patients with a suspicion of infective endocarditis: be part of the team! J Nucl Cardiol. 2015:1–5.
19. Thurlow LR, Thomas VC, Narayanan S, Olson S, Fleming SD, Hancock LE. Gelatinase contributes to the pathogenesis of endocarditis caused by Enterococcus faecalis. Infect Immun. 2010;78:4936–43.
20. Cheung GYC, Rigby K, Wang R, Queck SY, Braughton KR, Whitney AR, et al. Staphylococcus epidermidis strategies to avoid killing by human neutrophils. PLoS Pathog. 2010;6:15–6.
21. 18 F]FDG uptake as a novel major criteria in prosthetic valve endocarditis.
22. 18 F]FDG-PET for the diagnosis of cardiac infections.
23. 18F-FDG PET/CT in infectious endocarditis: a systematic review and meta- analysis. Int J Clin Pharmacol Ther. 2016;54:337–42.
24. Ahmed FZ, James J, Memmott MJ, Arumugam P. Radionuclide imaging of cardiovascular infection. Cardiol Clin. 2016;34:149–65.
25. Sarikaya I. Cardiac applications of PET. Nucl Med Commun. 2015;36:971–85.
26. Chen W, Kim J, Molchanova-Cook OP, Dilsizian V. The potential of FDG PET/CT for early diagnosis of cardiac device and prosthetic valve infection before morphologic damages ensue. Curr Cardiol Rep. 2014;16:459.
27. Jenkins WSA, Chin C, Rudd JHF, Newby DE, Dweck MR. What can we learn about valvular heart disease from PET/CT? Futur Cardiol. 2013;9:657–67.
28. Balmforth D, Chacko J, Uppal R. Does positron emission tomography/computed tomography aid the diagnosis of prosthetic valve infective endocarditis? Interact. Cardiovasc. Thorac. Surg. 2016;ivw177.
29. •• Tanis W, Budde RPJ, Van Der Bilt IAC, Delemarre B, Hoohenker G, Van Rooden JK, et al. Novel imaging strategies for the detection of prosthetic heart valve obstruction and endocarditis. Netherlands Hear J. 2016;24:96–107. This paper reviews the role of novel imaging tools in the field of prosthetic heart valve obstruction and endocarditis.
30. Orvin K, Goldberg E, Bernstine H, Groshar D, Sagie A, Kornowski R, et al. The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis. Clin Microbiol Infect. 2015;21:69–76.
31. Ricciardi A, Sordillo P, Ceccarelli L, Maffongelli G, Calisti G, Di Pietro B, et al. 18-Fluoro-2-deoxyglucose positron emission tomography-computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis. Int J Infect Dis. 2014;28:219–24.
32. 18F-FDG PET in patients with infectious endocarditis. J Nucl Med. 2014;55:1093–8.
33. 18F-FDG PET/CT in diagnosing infectious endocarditis. Eur J Nucl Med Mol Imaging. 2013;40:1102–7.
34. 18F-FDG-PET/CT in the extra cardiac work-up of patients with infective endocarditis. Eur Heart J Cardiovasc Imaging. 2014;15:1013–9.
35. 18F-FDG positron emission tomography/computed tomography in infective endocarditis. J Nucl Cardiol. 2015:1–12.
36. 18 F]FDG PET/CT and MDCTA.
37. 18F-fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation. 2015;132:1113–26.
38. 18F-FDG PET/CT in infective endocarditis and implantable cardiac electronic device infection: a cross-sectional study. J Nucl Med. 2016:15–6.
39. 18F–FDG PET/CT in the diagnosis of prosthetic valve endocarditis. Int. J. Cardiovasc. Imaging. 2015;679–86.
40. de Groot M, Meeuwis APW, Kok PJM, Corstens FHM, Oyen WJG. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging. 2005;32:98–101.
41. Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013;54:1485–507.
42. Osborne MT, Hulten EA, Murthy VL, Skali H, Taqueti VR, Dorbala S, et al. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol. 2017;24:86–99.
43. Fan C-M, Fischman AJ, Kwek BH, Abbara S, Aquino SL. Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET. AJR Am J Roentgenol. 2005;184:339–42.
44. Scholtens AM, Swart LE, Verberne HJ, Tanis W, Lam MGEH, Budde RPJ. Confounders in FDG-PET/CT imaging of suspected prosthetic valve endocarditis. JACC Cardiovasc. Imaging. 2016;27344422.
45. 18F–FDG PET/CT uptake of a nonbacterial thrombotic endocarditis. J. Nucl. Cardiol. 2016;27000880.
46. 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med. 2014;55:1980–5.
47. 18F-FDG-PET/CTA of prosthetic cardiac valves and valve-tube grafts. JACC Cardiovasc Imaging. 2016;9:9–12.
48. Scholtens AM, van Aarnhem EEHL, Budde RP. Effect of antibiotics on FDG-PET/CT imaging of prosthetic heart valve endocarditis. Eur Hear J – Cardiovasc Imaging. 2015;16:1223.
49. Yilmaz S, Aliyev A, Ekmekcioglu O, Ozhan M, Uslu L, Vatankulu B, et al. Comparison of FDG and FDG-labeled leukocytes PET/CT in diagnosis of infection. Nuklearmedizin. 2015;54:262–71.